Doctor behind trial of HIV prevention drug recounts breakthrough moment
Briefly

The problem of how to prevent HIV infection, particularly in teenage girls and young women, had seemed intractable, Bekker said. But lenacapavir had offered thousands of women aged 16 to 25 in South Africa and Uganda 100% protection.
But they are not reaching everyone who needs them and while most new infections now occur outside sub-Saharan Africa, the UN says HIV incidence among teenagers and young women remains extraordinarily high in parts of the region, with more than 150,000 infected there last year.
Read at www.theguardian.com
[
]
[
|
]